NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
Go back to NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.| (NASDAQ: NRXP) | Delayed: 3.85 -0.05 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.90 | 52 Week High | $ | |||
| Open | $3.80 | 52 Week Low | $ | |||
| Day High | $3.92 | P/E | N/A | |||
| Day Low | $3.78 | EPS | $ | |||
| Volume | 81,682 | |||||
